home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post navigation
Previous Post
Previous
Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300
Next Post
Next
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer